1. Home
  2. HOWL vs NMS Comparison

HOWL vs NMS Comparison

Compare HOWL & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • NMS
  • Stock Information
  • Founded
  • HOWL 2017
  • NMS 1993
  • Country
  • HOWL United States
  • NMS United States
  • Employees
  • HOWL N/A
  • NMS N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • NMS Finance Companies
  • Sector
  • HOWL Health Care
  • NMS Finance
  • Exchange
  • HOWL Nasdaq
  • NMS Nasdaq
  • Market Cap
  • HOWL 87.4M
  • NMS 76.2M
  • IPO Year
  • HOWL 2021
  • NMS N/A
  • Fundamental
  • Price
  • HOWL $1.79
  • NMS $13.30
  • Analyst Decision
  • HOWL Strong Buy
  • NMS
  • Analyst Count
  • HOWL 2
  • NMS 0
  • Target Price
  • HOWL $13.50
  • NMS N/A
  • AVG Volume (30 Days)
  • HOWL 656.6K
  • NMS 12.0K
  • Earning Date
  • HOWL 11-07-2024
  • NMS 01-01-0001
  • Dividend Yield
  • HOWL N/A
  • NMS 4.11%
  • EPS Growth
  • HOWL N/A
  • NMS N/A
  • EPS
  • HOWL N/A
  • NMS N/A
  • Revenue
  • HOWL $3,386,000.00
  • NMS N/A
  • Revenue This Year
  • HOWL N/A
  • NMS N/A
  • Revenue Next Year
  • HOWL $191.98
  • NMS N/A
  • P/E Ratio
  • HOWL N/A
  • NMS N/A
  • Revenue Growth
  • HOWL N/A
  • NMS N/A
  • 52 Week Low
  • HOWL $1.58
  • NMS $9.21
  • 52 Week High
  • HOWL $8.19
  • NMS $12.18
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 32.55
  • NMS 53.98
  • Support Level
  • HOWL $1.58
  • NMS $13.05
  • Resistance Level
  • HOWL $2.24
  • NMS $13.56
  • Average True Range (ATR)
  • HOWL 0.16
  • NMS 0.26
  • MACD
  • HOWL -0.09
  • NMS -0.00
  • Stochastic Oscillator
  • HOWL 7.01
  • NMS 46.05

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About NMS Nuveen Minnesota Quality Municipal Income Fund

Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.

Share on Social Networks: